Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is …

Mounjaro (tirzepatide) 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be …

Mounjaro is a once-weekly injectable prescription medicine to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It should be used along with diet and exercise.

Mounjaro (tirzepatide), an injectable prescription medicine, is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Mounjaro has not been studied in patients with a history of pancreatitis. Mounjaro is not indicated for use in patients with type 1 diabetes mellitus.

MOUNJARO is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is not known if MOUNJARO can be used in people who have had pancreatitis.

MOUNJARO is a clear and colourless to slightly yellow solution that is free of particles. Table 1 lists the dosage forms, strengths, composition, and packaging for each presentation.

Apr 27, 2023 · Mounjaro ® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. About Lilly Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our ...

Are you eligible for the Mounjaro Savings Card? If you are eligible, you may pay as little as $25 for a 1-month or 3-month prescription of Mounjaro. * See how to get a Mounjaro Savings Card below. *For eligible commercially insured patients with Mounjaro coverage. Governmental beneficiaries excluded. See eligibility requirements.

covers Mounjaro®(tirzepatide) and a prescription consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Mounjaro. Month is defined as 28-days and up to 4 pens.

Assistance is available to qualified patients in paying for their medication. See important safety information, including boxed warning, in the attached prescribing information. Please visit https://www.mounjaro.com/hcp/savings-resources. MOUNJARO® (tirzepatide) injection, for subcutaneous use, Lilly. Are you satisfied with this content?